欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Biktarvy	Human	bictegravir;emtricitabine;tenofovir alafenamide	bictegravir;emtricitabine;tenofovir alafenamide;fumarate	EMEA/H/C/004449	Gilead Sciences Ireland UC	2018/06/21	Authorised
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil succinate	EMEA/H/C/004274	KRKA, d.d., Novo mesto	2018/02/08	Authorised
Symtuza	Human	darunavir;cobicistat;emtricitabine;tenofovir alafenamide	darunavir;cobicistat;emtricitabine;tenofovir alafenamide	EMEA/H/C/004391	Janssen-Cilag International NV	2017/09/21	Authorised
Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil maleate	EMEA/H/C/004240	Mylan Pharmaceuticals Limited	2017/09/05	Authorised
Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil phosphate	EMEA/H/C/004250	Zentiva k.s.	2017/07/17	Authorised
Emtricitabine/Tenofovir disoproxil Krka d.d.	Human	emtricitabine;tenofovir disoproxil	emtricitabine;tenofovir disoproxil succinate	EMEA/H/C/004686	KRKA, d.d., Novo mesto	2017/04/28	Authorised
Emtricitabine/Tenofovir disoproxil Mylan	Human	emtricitabine;tenofovir disoproxil	emtricitabine;tenofovir disoproxil maleate	EMEA/H/C/004050	Mylan Pharmaceuticals Limited	2016/12/16	Authorised
Emtricitabine/Tenofovir disoproxil Krka	Human	emtricitabine;tenofovir disoproxil	emtricitabine;tenofovir disoproxil succinate	EMEA/H/C/004215	KRKA, d.d., Novo mesto	2016/12/09	Authorised
Emtricitabine/Tenofovir disoproxil Zentiva	Human	emtricitabine;tenofovir disoproxil	emtricitabine;tenofovir disoproxil phosphate	EMEA/H/C/004137	Zentiva k.s.	2016/11/09	Authorised
Odefsey	Human	emtricitabine;rilpivirine;tenofovir alafenamide	emtricitabine;rilpivirine hydrochloride;tenofovir alafenamide	EMEA/H/C/004156	Gilead Sciences Ireland UC	2016/06/21	Authorised
Descovy	Human	emtricitabine;tenofovir alafenamide	emtricitabine;tenofovir alafenamide	EMEA/H/C/004094	Gilead Sciences Ireland UC	2016/04/21	Authorised
Genvoya	Human	elvitegravir;cobicistat;emtricitabine;tenofovir alafenamide	elvitegravir;cobicistat;emtricitabine;tenofovir alafenamide	EMEA/H/C/004042	Gilead Sciences Ireland UC	2015/11/19	Authorised
Stribild	Human	elvitegravir;cobicistat;emtricitabine;tenofovir disoproxil	elvitegravir;cobicistat;emtricitabine;tenofovir disoproxil fumarate	EMEA/H/C/002574	Gilead Sciences Ireland UC	2013/05/24	Authorised
Eviplera	Human	emtricitabine;rilpivirine;tenofovir disoproxil	emtricitabine;rilpivirine hydrochloride;tenofovir disoproxil fumarate	EMEA/H/C/002312	Gilead Sciences International Ltd	2011/11/27	Authorised
Atripla	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil fumarate	EMEA/H/C/000797	Gilead Sciences Ireland UC	2007/12/13	Withdrawn
Truvada	Human	emtricitabine;tenofovir disoproxil	emtricitabine;tenofovir disoproxil fumarate	EMEA/H/C/000594	Gilead Sciences Ireland UC	2005/02/20	Authorised
Emtriva	Human	emtricitabine	emtricitabine	EMEA/H/C/000533	Gilead Sciences Ireland UC	2003/10/24	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-